home / stock / snoa / snoa news

SNOA News and Press, Sonoma Pharmaceuticals Inc. From 04/23/25

Stock Information
Company Name: Sonoma Pharmaceuticals Inc.
Stock Symbol: SNOA
Market: NASDAQ
Website: sonomapharma.com
Menu
SNOA SNOA Quote SNOA Short SNOA News SNOA Articles SNOA Message Board
Get SNOA Alerts

News, Short Squeeze, Breakout and More Instantly...
SNOA - Sonoma Pharmaceuticals Launches in Major UK Pharmacy Chain after Securing UK Registration for Acne Products

2025-04-23 07:16:48 ET DENVER, Colo., Apr 23, 2025 ( 247marketnews.com )- Sonoma Pharmaceuticals (NASDAQ:SNOA) reported the successful registration of its HOCl-based acne products with the U.K.’s Medicines & Healthcare products Regulatory Agency (MHRA). The registration paves...
SNOA - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, ...

SNOA - Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) is One of Tuesday Morning's Most Active Stocks

2025-03-11 10:03:21 ET Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is one today’s most active stocks by volume. So far today, approximately 44.37M shares of Sonoma Pharmaceuticals, Inc. have been exchanged, as compared to an average 30-day volume of 1.7M shares. Sonoma Pharma...

SNOA - Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, ...
SNOA - Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, ey...

SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M

2025-02-05 17:05:31 ET More on Sonoma Pharmaceuticals Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals Historical earnings data for Sonoma Pharmaceuticals Financial information for Sonoma Pharmaceuticals Read the full article on Seeking Alpha ...

SNOA - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Revenues increased 14% for the quarter compared to prior year and 13% year-to-date Positive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024 Year-to-date net loss decline of $1.1 million BOULDER, CO / ACCESS Newswire / February 5, 202...
Previous 10 Next 10